Superseded public profile

FDA-approved↗Reproductive health↗

Superseded · version 3: Bremelanotide↗

Related names recorded in this version: Vyleesi, PT-141↗

A melanocortin receptor agonist peptide. This profile cites a U.S. label record.↗

This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 29, 2026

We added search aliases that the cited FDA substance-identity record maps to this active ingredient. The profile's status did not change. 2

What this version reported

The cited DailyMed label identifies Bremelanotide and contains the product's official indications and warnings. This profile links to the label without restating it as medical guidance.↗

Organizations named in cited records:
  • U.S. National Library of Medicine↗

Sources for this version

  1. 1
    VYLEESI (bremelanotide) injection · SPL version 1 · published 2025-11-18 ↗

    DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026

  2. 2
    Bremelanotide substance identity record ↗

    FDA Global Substance Registration System · Official source · Source checked July 29, 2026